166 related articles for article (PubMed ID: 20703465)
1. Prognostic significance of ki-67 labeling index in papillary thyroid carcinoma.
Ito Y; Miyauchi A; Kakudo K; Hirokawa M; Kobayashi K; Miya A
World J Surg; 2010 Dec; 34(12):3015-21. PubMed ID: 20703465
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival.
Ito Y; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
World J Surg; 2006 May; 30(5):780-6. PubMed ID: 16411013
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of patients with papillary thyroid carcinoma after the detection of distant recurrence.
Ito Y; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2010 Oct; 34(10):2333-7. PubMed ID: 20628741
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of Ki-67 labeling index in minimally invasive follicular thyroid carcinoma.
Ito Y; Hirokawa M; Miyauchi A; Masuoka H; Yabuta T; Fukushima M; Kihara M; Higashiyama T; Kobayashi K; Miya A
Endocr J; 2016 Oct; 63(10):913-917. PubMed ID: 27432822
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of patients with papillary thyroid carcinoma showing postoperative recurrence to the central neck.
Ito Y; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2011 Apr; 35(4):767-72. PubMed ID: 21181469
[TBL] [Abstract][Full Text] [Related]
6. TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors.
Matsuse M; Yabuta T; Saenko V; Hirokawa M; Nishihara E; Suzuki K; Yamashita S; Miyauchi A; Mitsutake N
Sci Rep; 2017 Feb; 7():41752. PubMed ID: 28150740
[TBL] [Abstract][Full Text] [Related]
7. Ki-67 labeling index is a predictor of postoperative persistent disease and cancer growth and a prognostic indicator in papillary thyroid carcinoma.
Miyauchi A; Kudo T; Hirokawa M; Ito Y; Kihara M; Higashiyama T; Yabuta T; Masuoka H; Shindo H; Kobayashi K; Miya A
Eur Thyroid J; 2013 Mar; 2(1):57-64. PubMed ID: 24783039
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of BRAF (V600E) mutation and Ki-67 labeling index in papillary thyroid carcinomas.
Nakayama H; Yoshida A; Nakamura Y; Hayashi H; Miyagi Y; Wada N; Rino Y; Masuda M; Imada T
Anticancer Res; 2007; 27(5B):3645-9. PubMed ID: 17972530
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of extrathyroid extension and clinical lymph node metastasis in papillary thyroid carcinoma depend on carcinoma size.
Fukushima M; Ito Y; Hirokawa M; Miya A; Shimizu K; Miyauchi A
World J Surg; 2010 Dec; 34(12):3007-14. PubMed ID: 20824274
[TBL] [Abstract][Full Text] [Related]
10. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of the Proportion of Tall Cell Components in Papillary Thyroid Carcinoma.
Ito Y; Hirokawa M; Miyauchi A; Higashiyama T; Kihara M; Miya A
World J Surg; 2017 Mar; 41(3):742-747. PubMed ID: 27807709
[TBL] [Abstract][Full Text] [Related]
13. Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma.
Lee YS; Ha SA; Kim HJ; Shin SM; Kim HK; Kim S; Kang CS; Lee KY; Hong OK; Lee SH; Kwon HS; Cha BY; Kim JW
Exp Mol Pathol; 2010 Feb; 88(1):138-42. PubMed ID: 19818763
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an intraoperative staging system (iStage) by improving UICC TNM classification system for papillary thyroid carcinoma.
Ito Y; Ichihara K; Masuoka H; Fukushima M; Inoue H; Kihara M; Tomoda C; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2010 Nov; 34(11):2570-80. PubMed ID: 20625728
[TBL] [Abstract][Full Text] [Related]
15. Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients.
Ito Y; Miyauchi A; Kihara M; Fukushima M; Higashiyama T; Miya A
World J Surg; 2018 Mar; 42(3):615-622. PubMed ID: 29349484
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of carcinoma extension from primary lesions and metastatic nodes in papillary thyroid carcinoma: appropriateness of three subdivisions of extension.
Ito Y; Kudo T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2011; 58(11):961-7. PubMed ID: 21869536
[TBL] [Abstract][Full Text] [Related]
17. Role of Ki-67 as a proliferative marker in lesions of thyroid.
Pujani M; Arora B; Pujani M; Singh SK; Tejwani N
Indian J Cancer; 2010; 47(3):304-7. PubMed ID: 20587907
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma.
Viana AOR; Gonçalves Filho J; Francisco ALN; Pinto CAL; Kowalski LP
Acta Otorhinolaryngol Ital; 2020 Jun; 40(3):190-197. PubMed ID: 32773780
[TBL] [Abstract][Full Text] [Related]
19. MIB-1 index in thyroid tumors: a predictor of the clinical course in papillary thyroid carcinoma.
Kjellman P; Wallin G; Höög A; Auer G; Larsson C; Zedenius J
Thyroid; 2003 Apr; 13(4):371-80. PubMed ID: 12812214
[TBL] [Abstract][Full Text] [Related]
20. CD147 expression as a significant prognostic factor in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Transl Res; 2008 Sep; 152(3):143-9. PubMed ID: 18774544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
